3 completed, 1 active not recruiting, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow BPGbio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) BPM31510, Vitamin K1, Temozolomide (TMZ) - Glioblastoma, Glioblastoma Multiforme | Phase 2 | Active not recruiting | BPGbio | 50 | 2022-08-22 | 2026-01-26 |
| BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients BPM31510 Nanosuspension Injection, Gemcitabine - Pancreatic Cancer | Phase 2 | Completed | BPGbio | 45 | 2016-07-06 | 2025-03-26 |
| An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) API 31510 - Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 35 | 2008-06-01 | 2019-03-05 |
| Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo - Superficial Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 186 | 2008-03-01 | 2025-02-28 |
| Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma API 31510 Topical Cream - Squamous Cell Carcinoma | Phase 2 | Withdrawn | BPGbio | 2008-03-01 | 2012-07-25 |
Carcinoma, Squamous Cell (2) · Glioblastoma (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Gemcitabine (1) · Radiation (1) · Temozolomide (1) · Vitamin K 1 (1) · coenzyme Q10 (1)
United States (4) · United Kingdom (1)
David Wilson, MD (1) · Ramesh K Ramanathan, MD (1)